“Dose Adjustment Patterns in the Open-Label Extension Arms of Three Phase 3 Trials of Certolizumab Pegol in Psoriasis: CIMPASI-1, CIMPASI-2, and CIMPACT”. SKIN The Journal of Cutaneous Medicine, vol. 4, no. 6, Oct. 2020, p. s85, https://doi.org/10.25251/skin.4.supp.85.